Galmed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.About GLMD
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.
CEOAllen Baharaff
CEOAllen Baharaff
Employees8
Employees8
HeadquartersRamat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded2000
Founded2000
Employees8
Employees8
GLMD Key Statistics
Market cap2.52M
Market cap2.52M
Price-Earnings ratio-0.16
Price-Earnings ratio-0.16
Dividend yield—
Dividend yield—
Average volume58.11K
Average volume58.11K
High today$0.43
High today$0.43
Low today$0.3615
Low today$0.3615
Open price$0.39
Open price$0.39
Volume152.83K
Volume152.83K
52 Week high$6.00
52 Week high$6.00
52 Week low$0.26
52 Week low$0.26